Search

everythinglearnresearchcommunity

for

Search:↓

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Finasteride effectively treats male hair loss, improving growth and density.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Purple corn extract may help reduce prostate enlargement and inflammation.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

Finasteride may cause kidney damage.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

MK-386 lowers DHT in blood and skin but not in semen.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Finasteride effectively reduces hair loss by decreasing androgen levels.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Androgenetic alopecia is common hair loss due to genetics and DHT.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Finasteride treats baldness but may cause lasting sexual side effects.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.